Connect with us

National

The world is hungry for mRNA COVID vaccines like Pfizer’s. But we’re short of vital components – UNSW Newsroom

Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of Pfizer’s and other mRNA vaccines.

Published

on

Article feature image

Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of Pfizer’s and other mRNA vaccines.Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to plug the gap.
Pfizers mRNA vaccine will become the mainstay of the rollout, with 40 million doses expected to arrive before years end.
But Australia isnt the only country eager to get its hand on…

Click here to view the original article.